Logotipo do repositório
 

Publicação:
Pharmacological modulation of allergic inflammation in the rat airways and association with mast cell heterogeneity

dc.contributor.authorDamazo, A. S.
dc.contributor.authorde Lima, W. T.
dc.contributor.authorPerretti, M.
dc.contributor.authorOliani, S. M.
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.contributor.institutionSt Bartholomews & Royal London Sch Med & Dent
dc.date.accessioned2014-05-20T15:21:23Z
dc.date.available2014-05-20T15:21:23Z
dc.date.issued2001-08-24
dc.description.abstractAdministration of ovalbumin by aerosol to sensitised rats produced a rapid (15 min) protein exudation in different airway tissues, as determined by Evans blue staining. This was associated with marked mast cell degranulation determined by histological examination, with there being no difference between mucosal and connective tissue mast cells. A 5-day administration regimen with compound 48/80 selectively depleted connective tissue mast cell (Positive to berberine staining) without modifying ovalbumin-induced plasma protein extravasation. Treatment of rats with dexamethasone (1 mg/kg, - 12 h) or nor-dihydroguaiaretic acid (30 mg/kg i.p., - 30 min) significantly reduced ovalbumin-induced protein extravasation and preserved mucosal mast cell morphology. Indomethacin (4 mg/kg i.v., - 30 min) exerted no effect on either parameter. In conclusion, we propose the mucosal mast cell as a target cell responsible at least partly for the inhibitory actions of known anti-inflammatory drugs. We suggest an involvement of endogenous leukotriene(s), but not prostanoid(s), in mucosal mast cell activation/degranulation. (C) 2001 Published by Elsevier B.V. B.V.en
dc.description.affiliationUNESP, Inst Biociencias Letras & Ciências Exatas, Dept Biol, São Paulo, Brazil
dc.description.affiliationUSP, ICB, Dept Pharmacol, São Paulo, Brazil
dc.description.affiliationSt Bartholomews & Royal London Sch Med & Dent, William Harvey Res Inst, Div Pharmacol, London, England
dc.description.affiliationUnespUNESP, Inst Biociencias Letras & Ciências Exatas, Dept Biol, São Paulo, Brazil
dc.format.extent123-130
dc.identifierhttp://dx.doi.org/10.1016/S0014-2999(01)01093-7
dc.identifier.citationEuropean Journal of Pharmacology. Amsterdam: Elsevier B.V., v. 426, n. 1-2, p. 123-130, 2001.
dc.identifier.doi10.1016/S0014-2999(01)01093-7
dc.identifier.issn0014-2999
dc.identifier.urihttp://hdl.handle.net/11449/32539
dc.identifier.wosWOS:000170879000017
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.ispartofEuropean Journal of Pharmacology
dc.relation.ispartofjcr3.040
dc.relation.ispartofsjr1,057
dc.rights.accessRightsAcesso restritopt
dc.sourceWeb of Science
dc.subjectdexamethasonept
dc.subjectindomethacinpt
dc.subjectnor-dihydroguaiaretic acidpt
dc.subjectplasma protein extravasationpt
dc.subjectcompound 48/80pt
dc.subjectmast cellpt
dc.titlePharmacological modulation of allergic inflammation in the rat airways and association with mast cell heterogeneityen
dc.typeArtigopt
dcterms.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dcterms.rightsHolderElsevier B.V.
dspace.entity.typePublication
unesp.campusUniversidade Estadual Paulista (UNESP), Instituto de Biociências, Letras e Ciências Exatas, São José do Rio Pretopt

Arquivos

Licença do Pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: